Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00147823 · ClinicalTrials.gov registry record · NA

Comparing Synthetic Bone Alone Versus Synthetic Bone With Bone Marrow in Bone Lesions

A NA study, sponsored by State University of New York - Upstate Medical University.

Completed
Registry status
NA
Development phase
63
Enrollment target

NCT00147823 is a NA study that has completed, run by State University of New York - Upstate Medical University. The registered enrollment target is 63 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00147823, a NA study, has completed, sponsored by State University of New York - Upstate Medical University.

COMPLETED
Registry status
NA
Development phase
63 participants
Enrollment target

Study Summary

This is a prospective randomized study comparing Vitoss alone versus Vitoss with bone marrow aspirate in benign bone lesions.

Interventions

  • DEVICE Vitoss Alone
  • DEVICE Vitoss with Bone Marrow Aspirate

Trial Details

FieldValue
Enrollment Target 63 participants
Start Date 2004-12
Est. Completion 2011-12
Phase NA

What the Registry Record Tells You About NCT00147823

The ClinicalTrials.gov registry entry for NCT00147823 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 63 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is State University of New York - Upstate Medical University, which has 113 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Vitoss Alone is the first listed.

NCT00147823 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00147823 about?

NCT00147823 is a clinical study titled "Comparing Synthetic Bone Alone Versus Synthetic Bone With Bone Marrow in Bone Lesions". This is a prospective randomized study comparing Vitoss alone versus Vitoss with bone marrow aspirate in benign bone lesions.

What is the current status of trial NCT00147823?

This trial is currently completed. It is a NA study. The enrollment target is 63 participants. The study started on 2004-12. Estimated completion is 2011-12.

What interventions are being tested in trial NCT00147823?

The interventions under investigation include: Vitoss Alone (DEVICE), Vitoss with Bone Marrow Aspirate (DEVICE).

Who is sponsoring clinical trial NCT00147823?

This trial is sponsored by State University of New York - Upstate Medical University, which has 113 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.